WELLAGE Hyaluronic Acid Micro Needle (HUGEL PHARMA CO.,LTD) HYALURONIC ACID 9. Dosage form: patch. Ingredients: HYALURONIC ACID 9. Labeler: HUGEL PHARMA CO.,LTDNDC Code: 6. Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. If swallowing, drink plenty of water and contact a physician. WELLAGE HYALURONIC ACID MICRO NEEDLE. Product Information. Product Type. HUMAN OTC DRUGItem Code (Source)NDC: 6. The Anti Wrinkle Hyaluronic Acid Filler Patch promotes the pigeon hobby through fellowship, education, and competition. The NPA sponsors and encourages participation in the Grand National Pigeon Show held each year at. Skinova AcroPass Hyaluronic Patches With Transdermal Nano Technology (TDN) This revolutionary product uses patented technology to deliver and replenish Hyaluronic acid into the skin without pain or side effects and with. Wellage Hyaluronic Acid Micro Needle Patch Recommended for use on the area of the nasolabial folds, the area of skin and eyes. Hyaluronic Acid Gel Patches, Wholesale Various High Quality Hyaluronic Acid Gel Patches Products from Global Hyaluronic Acid Gel Patches Suppliers and Hyaluronic Acid Gel Patches Factory,Importer,Exporter at Alibaba.com. Transdermal delivery of hyaluronic acid -- human growth hormone conjugate. Yang JA(1), Kim ES, Kwon JH, Kim H, Shin JH, Yun SH. Route of Administration. TOPICALDEA Schedule. Active Ingredient/Active Moiety. Ingredient Name. Basis of Strength. Strength. HYALURONIC ACID (HYALURONIC ACID) HYALURONIC ACID9. Inactive Ingredients. Ingredient Name. Strength. LACTOSE Packaging#Item Code. Package Description. NDC: 6. 93. 46- 9. PACKETMarketing Information. Marketing Category. Out of scope - Out of scope for RxNorm and will not receive RxNorm normal forms. Out of scope information includes radiopharmaceuticals, contrast media, herbals, homeopathics, and food. Drug names that are ambiguous or not. Hyaluronic acid based scaffolds for tissue engineering—A review. Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. Application Number or Monograph Citation. Marketing Start Date. Marketing End Dateunapproved drug other. Labeler - HUGEL PHARMA CO.,LTD. Registrant - HUGEL PHARMA CO.,LTD (6. Establishment. Name. Address. ID/FEIOperations. HUGEL PHARMA CO.,LTD6. Revised: 0. 5/2. 01. HUGEL PHARMA CO.,LTDDisclaimer: Every effort has been made to ensure that the information provided here is accurate, up- to- date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
December 2016
Categories |